During the past decade, Brain Resource Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Brain Resource Center" are "Attention Deficit/Hyperactivity Disorder" (1 trials), "Attention-deficit/Hyperactivity Disorder" (1 trials), "Major Depressive Disorder" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Brain Resource Center" in a lesser frequency.

Most popular intervention types in "Brain Resource Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cymbalta" (1 trials), "Escitalopram" (1 trials), "Lisdexamfetamine dimesylate" (1 trials), "Long Acting Methylphenidate" (1 trials) and "Methylphenidate Hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Brain Resource Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Brain Resource Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Brain Resource Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Brain Resource Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".